跳至主要内容
临床试验/CTRI/2020/06/026195
CTRI/2020/06/026195已完成2 期

Effectiveness of Individualized homoeopathy as an add-on to standard treatment of COVID-19 - A multicentric, randomized, parallel arm, single blind, placebo, controlled study

Central Council for Research in Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
已完成
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Hospitalized symptomatic patients with COVID-19 infection
  • 2.Age between 18 years to 80 years
  • 3.Both the sexes
  • 4.Willing to give written informed consent

排除标准

  • 1.Severe heart, lung, kidney, brain, blood diseases or other important systemic diseases
  • 2.Patients on ventilatory support
  • 3.Immunocompromised patients
  • 4.Subjects considered to be unable to complete the study, or not suitable for the study by researchers.
  • 5.Women during pregnancy.
  • 6.Lactating mothers

研究者

发起方
Central Council for Research in Homoeopathy

相似试验